NAD+ Near Me: Priced by the Session, Sold by the Gram

Most of the near me pages on this site end the same way, which is that the local results cannot lawfully sell you the thing you searched for. NAD+ near me is the exception, and it is worth saying so at the top rather than burying it. Drip bars, med spas, longevity practices and IV therapy lounges do administer NAD+ infusions, openly, in most of the country, and the appointment you can book this afternoon is a real appointment for a real preparation.

That changes the shape of the advice. The question is not whether the listing is a front for something else. It is what the clinic is putting in the bag, where the raw material came from, what it costs against the alternative, and what the evidence supports. This page works through them in that order.

The alternative sits at the top of this page: a 1,000 mg vial of NAD+ as research material, $104.00 list and $52.00 with the code, from a supplier we have an affiliate arrangement with, set out in our affiliate disclosure. That route is not supervised, and a fair comparison has to start by admitting what a clinic provides that a cardboard box does not.

Local NAD+ listings fall into a small number of shapes, and naming them makes the map far less confusing. The most common is an intravenous infusion of a compounded NAD+ preparation, run over a period of hours, sold as a single session or as a course. The second is a shot, quicker and cheaper, which NPR reported can still carry a price tag rising to several hundred dollars. The third is a blend, where NAD+ appears alongside amino acids, B vitamins or other nutritional components. NPR's 2019 reporting described NAD therapy as an IV infusion that can contain amino acids and other nutritional supplements alongside nicotinamide adenine dinucleotide, which is a good description of a large part of this market.

The fourth shape is a precursor infusion rather than NAD+ itself, and it is the one people do not realise they have booked. Precursors are sold on the same menus and marketed with the same language. If which molecule you receive matters to you, get the answer in writing before you pay a deposit, because a menu item name is not a formulation.

What clinics say the infusion is for varies more than what is in it. Marketing across this sector has attached NAD+ to addiction recovery, fatigue, depression, cognitive decline and ageing itself. We are reporting that clinics market it for these things, not adopting the claims, and neither the FDA list nor the literature supports them.

For NAD+ IV therapy near me, the most defensible price figure we can point at comes from NPR in May 2026, which reported that clinic infusions can run anywhere from $200 to upwards of $1,000 for one drip session. That is a national reporting range from a newsroom with nothing to sell, which is why we use it rather than surveying med spa price pages, most of which are incomplete by design.

Set that against $52.00 for a gram of research material and the multiple is stark, and it is also not a like for like comparison. The clinic fee covers a compounded sterile preparation, a nurse for the duration, a clinician who signed off, a room, insurance and margin. The vial covers a vial.

There is one number that would make the comparison honest and it is almost never disclosed: how many milligrams of NAD+ are in the bag. Ask for it. Without it, nobody can tell you whether one clinic's $300 session is better value than another's $600 session, let alone how either compares with a gram. A clinic that will not state the quantity has quoted you a fee rather than a price. Our NAD+ price page runs the full arithmetic and hits the same wall.

Pricing structures to expect locally, without inventing numbers for them: a single session rate, a discounted multi-session package bought up front, and sometimes a membership bundling infusions with other services. All three discount a rate the clinic set itself, so compare totals rather than percentages.

NPR's May 2026 piece opened with the problem that researchers studying NAD+ now have too much publicity around their subject. Christopher Martens, who directs the Delaware Center for Cognitive Aging Research and leads work in the field, told NPR that the cart may be well ahead of the horse. On the infusions specifically, the piece states there is almost no published data.

The most striking quote comes from inside the industry. Rachel Pojednic is chief science officer at Restore Hyper Wellness, described by NPR as a national chain offering NAD+ infusions, and is also a nutritional biochemist on the faculty at Stanford. She told NPR that preliminary findings from a pilot study in humans suggest NAD+ infusions are very inefficient at increasing levels in the cell, because NAD+ has no easy door to enter the cell from the bloodstream. She argued that infusions using a precursor, also offered by her company, are much more effective.

That is a science officer at a chain that sells the infusions telling a national newsroom that the infusions are inefficient at doing the thing they are sold to do. Whatever you conclude about NAD+ overall, take that sentence into the consultation with you and ask the clinic to respond to it.

The published human work is thin enough to summarise in a line. A 2019 pharmacokinetic pilot noted that no data were then available on the fate of directly infused NAD+ in a human cohort and set out to describe where the molecule goes. That is disposition, not benefit. NPR's bottom line in 2026 was that NAD+ products on the market are not proven to do the average person much good.

None of these require any chemistry and all of them are reasonable to ask a business you are about to pay several hundred dollars. A clinic doing this properly will already know the answers, because it will have asked its own supplier.

Ask how many milligrams of NAD+ you are receiving, and what else is in the preparation. Ask where the bulk substance came from and whether it was pharmaceutical grade or food grade. Ask whether the certificate of analysis for that bulk reports an endotoxin result, usually labelled LAL or bacterial endotoxins, rather than identity and purity alone. Ask who compounded it, and if the answer is an outsourcing facility, check the name against FDA's list of registered outsourcing facilities. Ask what happens if you react badly, who is in the building, and to whom it gets reported.

The endotoxin question is not pedantry, and FDA is the reason to ask it. In a notice with content current as of 10/30/2024, the agency wrote that it is aware of compounders using food-grade nicotinamide adenine dinucleotide (NAD+) sold by repackagers to make intravenous products, that food-grade ingredients are not suitable for compounding sterile drugs without appropriate processing because of the high risk of contamination with microbes and endotoxins, and that it has received adverse event reports after use of NAD+ injectable drugs including severe chills, shaking, vomiting and fatigue, some requiring medical treatment, consistent with excessive endotoxin levels.

Those adverse events happened to people in clinic chairs, not to people improvising at home. That is what makes this the single most useful question a local buyer can ask, and it is the question almost nobody asks.

One note on enforcement, because a clinic being open for business is not itself reassurance. NPR reported in 2019 that no publicly available information could be found showing that either FDA or the FTC had taken enforcement action against any clinic offering NAD treatments. An absence of enforcement is not a verdict.

For NAD+ injection near me, the honest framing is a trade rather than a winner. The clinic route buys preparation, supervision, insurance and a state board that can hear a complaint. The mail-order route buys a documented batch, a price you can verify, and nobody watching.

What does not change is the material. Grade and endotoxin status are decided upstream by whoever made and handled the powder, and are invisible from a treatment chair exactly as they are from a delivery box. FDA's notice was about domestic compounders buying from domestic repackagers, so paying more locally does not route around the problem.

What the mail-order route offers is inspection before purchase. You can read a certificate of analysis before spending anything, which is more than most people are shown at a drip bar. The listing we link states that two independent laboratories test every batch. We have not been shown an endotoxin figure for the NAD+ batches specifically, so we will not imply one exists. Ask before you order, and see our source assessment.

Handling and dosing arithmetic sit off this site by design, at PeptideDosage and its NAD+ calculator.

It would be unfair to leave the impression that the clinic in your search results has nothing to offer, because the reason people search for NAD+ is usually real. Fatigue, brain fog, a sense that recovery has slowed. Those are worth investigating, and a local practice is better equipped to do it than a vial is.

A clinic can run bloodwork and find something an infusion was never going to address. It can prescribe licensed medicines with a titration and someone watching, including the approved options we cover in our guide to GLP-1 medicines and map by city in our local care guide. It is inspected, insured and answerable to a state board, and when it gets something wrong there is a complaints route that leads somewhere.

The test we apply to a drip bar is the one we apply to every telehealth provider on this site. Can it tell you what you are receiving, where it came from, who is accountable, and what the evidence is. A clinic that answers those four plainly has earned the fee. One that gets vague about sourcing has answered too, and the answer it is avoiding is usually that it bought from the same market you could have.